Franklin Resources Inc. reduced its position in HealthEquity, Inc. (NASDAQ:HQY - Free Report) by 17.2% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 1,357,437 shares of the company's stock after selling 282,778 shares during the quarter. Franklin Resources Inc. owned 1.57% of HealthEquity worth $130,246,000 at the end of the most recent quarter.
Other institutional investors have also recently modified their holdings of the company. Holocene Advisors LP purchased a new stake in HealthEquity during the third quarter valued at about $1,246,000. Pier Capital LLC purchased a new position in HealthEquity in the 4th quarter worth approximately $8,024,000. HighTower Advisors LLC boosted its stake in shares of HealthEquity by 4.8% during the fourth quarter. HighTower Advisors LLC now owns 95,075 shares of the company's stock valued at $9,122,000 after purchasing an additional 4,370 shares during the period. Geneva Capital Management LLC grew its holdings in shares of HealthEquity by 24.6% in the fourth quarter. Geneva Capital Management LLC now owns 1,048,903 shares of the company's stock worth $100,642,000 after purchasing an additional 206,894 shares during the last quarter. Finally, BNP Paribas Financial Markets increased its stake in shares of HealthEquity by 165.7% in the third quarter. BNP Paribas Financial Markets now owns 20,437 shares of the company's stock worth $1,673,000 after buying an additional 12,745 shares during the period. 99.55% of the stock is currently owned by institutional investors.
Insider Activity
In other news, Director Robert W. Selander sold 5,750 shares of the company's stock in a transaction on Monday, February 10th. The stock was sold at an average price of $111.29, for a total transaction of $639,917.50. Following the transaction, the director now directly owns 78,219 shares of the company's stock, valued at $8,704,992.51. This represents a 6.85 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Corporate insiders own 2.20% of the company's stock.
HealthEquity Stock Down 5.0 %
Shares of HQY traded down $4.17 during trading hours on Friday, hitting $78.80. The company had a trading volume of 1,933,052 shares, compared to its average volume of 740,684. The stock has a market capitalization of $6.82 billion, a price-to-earnings ratio of 72.29, a P/E/G ratio of 1.60 and a beta of 0.49. The firm has a fifty day moving average price of $101.66 and a 200-day moving average price of $96.21. HealthEquity, Inc. has a 52-week low of $65.01 and a 52-week high of $115.59. The company has a debt-to-equity ratio of 0.51, a quick ratio of 3.20 and a current ratio of 3.20.
Analyst Ratings Changes
A number of brokerages have issued reports on HQY. Royal Bank of Canada raised their price target on shares of HealthEquity from $100.00 to $105.00 and gave the stock an "outperform" rating in a report on Tuesday, December 10th. JMP Securities lifted their price objective on HealthEquity from $105.00 to $107.00 and gave the stock a "market outperform" rating in a research report on Tuesday, December 10th. Barrington Research restated an "outperform" rating and set a $112.00 target price on shares of HealthEquity in a report on Friday, March 14th. The Goldman Sachs Group cut their price target on shares of HealthEquity from $107.00 to $94.00 and set a "neutral" rating on the stock in a report on Thursday, March 27th. Finally, Wells Fargo & Company lifted their target price on shares of HealthEquity from $110.00 to $125.00 and gave the company an "overweight" rating in a research note on Wednesday, February 26th. One equities research analyst has rated the stock with a hold rating, ten have given a buy rating and one has given a strong buy rating to the company's stock. According to data from MarketBeat, the stock presently has a consensus rating of "Buy" and an average target price of $112.58.
Check Out Our Latest Analysis on HQY
HealthEquity Company Profile
(
Free Report)
HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.
See Also
Before you consider HealthEquity, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and HealthEquity wasn't on the list.
While HealthEquity currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
